key: cord-1006867-yyrr4fzb
authors: Kandi, Lyndsay A.; Rebecca, Alanna M.; Howard, Michael A.; Teven, Chad M.
title: Lessons Learned during COVID-19: Safety of Vascularized Omental Lymphatic Transfer in the Outpatient Setting
date: 2022-03-18
journal: Plast Reconstr Surg Glob Open
DOI: 10.1097/gox.0000000000004231
sha: 205e0d41399bd3fefa9cb3e84abb861a9c29d7c4
doc_id: 1006867
cord_uid: yyrr4fzb

nan

has exacerbated the constant struggle that healthcare systems face due to a lack of resources necessary to provide adequate patient care to all. In particular, the impact of COVID-19 on surgical practice is multifarious, with issues including staffing, procedural prioritization, and surgical education bearing the brunt of suffering. 1 Further, constraints on hospital and bed capacity have exacerbated the problem and drastically impeded surgeons' abilities to provide necessary intervention. Efforts to mitigate this, including an acuity scale developed by Dorfman et al 2 to simplify surgical decision-making regarding canceling and postponing plastic surgery cases, have been made. Part of the challenge, particularly for plastic surgeons, is the heterogenous nature of cases performed and disagreement on acuity levels.

One example of this is the surgical treatment of lymphedema. Most guidelines, including Dorfman's, stratify lymphedema as low acuity (ie, Tier 1). 2 The implication is that these procedures can safely be postponed without undue harm to patients. Indeed, lymphedema is generally considered to be a slowly progressive disease process, often requiring years to reach the most severe stages. Specifically, stasis of lymph within affected tissue leads to a localized inflammatory process, resulting in progressive fibrosis, adipose tissue differentiation, and subsequent tissue enlargement. Although it is agreed that lymphedema is not usually an acute surgical emergency, its classification as a condition that can be postponed with minimal harm is incorrect. In contrast, our experience and the experience of others suggest that treatment delay by even a few weeks or months could lead to irreversible injury. 3 Our general approach to lymphedema management includes vascularized omental lymphatic transfer (VOLT) in appropriate patients. 4 Patients are typically admitted overnight to ensure appropriate bowel function and pain control. In the height of COVID-19-related capacity issues, however, overnight admission precluded our ability to offer lymphatic procedures. In light of recent research demonstrating the safety of same-day discharge for other procedures which historically required overnight admission, 5 we applied similar principles to selected patients undergoing VOLT. Patients were made aware of this change to our practice, and most of them strongly preferred undergoing surgical intervention as an outpatient rather than waiting for clearance. To date, four patients (57% of total) were managed this way. None experienced significant complications or required readmission; however, a larger sample size with longer follow-up is currently under review.

Two important conclusions stem from this viewpoint. First, same-day discharge after VOLT is safe and effective in appropriately selected patients (Table 1 ) and following additional precautions (Table 2) . Ongoing prospective investigations using a larger sample size will better characterize indications, advantages, and disadvantages of this approach. Second, the COVID-19 pandemic has 

The impact of COVID-19-based suspension of surgeries on plastic surgery practices: a survey of ACAPS members

The COVID-19 pandemic and plastic surgery: Literature review, ethical analysis, and proposed guidelines

Future prospects in lymphatic reconstructive surgery

Expanding the horizon: single-port robotic vascularized omentum lymphatic transplant

Same-day discharge is safe and effective after implant-based breast reconstruction

The authors have no financial interest to declare in relation to the content of this article.